The Woman's Hospital of Texas

Houston, Texas 77054

2 studies enrolling now · 22 studies all time

What they study most

Acute Pain, Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma, Atypical Endometrial Hyperplasia, Carcinomatosis, Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Contraception, Endometrial Cancer, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma

Studies at this site

• Humidity in Incubators for Tiny Infants — Recruiting now
• A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma — Completed
• A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP — Stopped early
• Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization — Completed
• PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer — Running, not enrolling
• Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Running, not enrolling
• Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer — Running, not enrolling
• Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer — Stopped early
• Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer — Running, not enrolling
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids — Stopped early
• Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer — Completed
• Preterm Infants Fed a Human Milk Fortifier — Starting soon
• Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Stopped early
• Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair — Status unconfirmed
• Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles — Completed
• Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer — Status unconfirmed
• Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery — Completed
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer — Completed
• Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas — Completed
• Myometrial Biopsy for the Detection of Infection — Status unconfirmed